Name of Information Collection: NASA Software Release Request System, 56474-56475 [2019-23020]
Download as PDF
<![CDATA[
56474
Federal Register / Vol. 84, No. 204 / Tuesday, October 22, 2019 / Notices
preliminarily determined meets the
requirements of the Criteria. The
following Plans are available for review:
• City of Tracy.
• Clear Creek Community Services
District.
• Sacramento County Water Agency.
• Westlands Water District.
We invite the public to comment on
our preliminary (i.e., draft)
determination of Plan adequacy.
A copy of these Plans will be
available for review at Reclamation’s
Mid-Pacific Regional Office, 2800
Cottage Way, CGB–410, Sacramento, CA
95825. If you wish to review a copy of
these Plans or to receive an electronic
copy via email, please contact Ms.
Stemen or visit https://www.usbr.gov/
mp/watershare/wcp.html.
Dated: October 16, 2019.
Richard Woodley,
Regional Resources Manager, Mid-Pacific
Region, Bureau of Reclamation.
[FR Doc. 2019–22958 Filed 10–21–19; 8:45 am]
BILLING CODE 4332–90–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 10, 2019,
Johnson Matthey, Inc., 2003 Nolte Drive,
West Deptford, New Jersey 08066–1743
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
[Docket No. DEA–524]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey, Inc.
ACTION:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 23, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
Notice of application.
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...................................................................................................................................
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
Dihydromorphine .....................................................................................................................................................
Difenoxin ..................................................................................................................................................................
Amphetamine ..........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
Lisdexamfetamine ...................................................................................................................................................
Methylphenidate ......................................................................................................................................................
Nabilone ..................................................................................................................................................................
Cocaine ...................................................................................................................................................................
Codeine ...................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................
Oxycodone ..............................................................................................................................................................
Hydromorphone .......................................................................................................................................................
Diphenoxylate ..........................................................................................................................................................
Ecgonine ..................................................................................................................................................................
Hydrocodone ...........................................................................................................................................................
Levorphanol .............................................................................................................................................................
Meperidine ...............................................................................................................................................................
Methadone ...............................................................................................................................................................
Methadone intermediate ..........................................................................................................................................
Morphine ..................................................................................................................................................................
Thebaine ..................................................................................................................................................................
Opium tincture .........................................................................................................................................................
Oxymorphone ..........................................................................................................................................................
Noroxymorphone .....................................................................................................................................................
Alfentanil ..................................................................................................................................................................
Remifentanil .............................................................................................................................................................
Sufentanil .................................................................................................................................................................
Tapentadol ...............................................................................................................................................................
Fentanyl ...................................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for internal use as
intermediates or for sale to its
customers. In reference to drug codes
7360 (marihuana), and 7370
(tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
Dated: October 9, 2019.
William T. McDermott,
Acting Assistant Administrator.
2010
7360
7370
9145
9168
1100
1105
1205
1724
7379
9041
9050
9120
9143
9150
9170
9180
9193
9220
9230
9250
9254
9300
9333
9630
9652
9668
9737
9739
9740
9780
9801
Schedule
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice: (19–070)]
[FR Doc. 2019–23012 Filed 10–21–19; 8:45 am]
Name of Information Collection: NASA
Software Release Request System
BILLING CODE 4410–09–P
National Aeronautics and
Space Administration (NASA).
ACTION: Notice of information
collection—new information collection.
AGENCY:
The National Aeronautics and
Space Administration, as part of its
SUMMARY:
VerDate Sep<11>2014
17:02 Oct 21, 2019
Jkt 250001
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
E:\FR\FM\22OCN1.SGM
22OCN1
Federal Register / Vol. 84, No. 204 / Tuesday, October 22, 2019 / Notices
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections.
DATES: Comments are due by December
23, 2019.
ADDRESSES: All comments should be
addressed to Claire Little, National
Aeronautics and Space Administration,
300 E Street SW, Washington, DC
20546–0001.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the information collection
instrument(s) and instructions should
be directed to Claire Little, NASA
Clearance Officer, NASA Headquarters,
300 E Street SW, JF0000, Washington,
DC 20546 or email claire.a.little@
nasa.gov.
SUPPLEMENTARY INFORMATION:
I. Abstract
NASA Software Release Request
System (SRRS) is a workflow tool that
allows Agency Software Release
Authorities (SRAs) to easily develop
and route software release documents,
such as the Software Release Request
Authorization (SRRA) and Section 508
Compliance Matrix in an automated
fashion. SRAs have the added ability to
perform parallel routing, including the
use of time-based email reminders,
tracking and reporting progress on the
processing of the software release
requests so they can effectively manage
this process at their respective centers.
Software owners/developers can submit
the Software Release Requests or view
their submitted Software Release
Requests that may need their attention.
II. Methods of Collection
Web based—only accessible via
NASA’s internal network (e.g., on site or
remotely via a NASA issued VPN)
III. Data
Title: NASA Software Release Request
System.
OMB Number: 2700–xxxx.
Type of review: New Information
Collection.
Affected Public: NASA Funded
Contractors and Government
Employees.
Average Expected Annual Number of
Activities: On average 126 software
packages are released per year.
Average number of Respondents per
Activity: At least one respondent will
complete the form per activity (software
release) which will result in
approximately 126 respondents.
Annual Responses: 126.
VerDate Sep<11>2014
17:02 Oct 21, 2019
Jkt 250001
Frequency of Responses: As needed.
Average minutes per Response: 240
minutes.
Burden Hours: 504.
IV. Request for Comments
Comments are invited on: (1) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of NASA, including
whether the information collected has
practical utility; (2) the accuracy of
NASA’s estimate of the burden
(including hours and cost) of the
proposed collection of information; (3)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on respondents, including automated
collection techniques or the use of other
forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the request for OMB
approval of this information collection.
They will also become a matter of
public record.
Cheryl Parker,
Federal Liaison Officer.
[FR Doc. 2019–23020 Filed 10–21–19; 8:45 am]
BILLING CODE 7510–13–P
NATIONAL ARCHIVES AND RECORDS
ADMINISTRATION
[FDMS docket: NARA–19–0015; Agency
number: NARA–2020–005]
Records Schedules; Availability and
Request for Comments
National Archives and Records
Administration (NARA).
ACTION: Notice of availability of
proposed records schedules; request for
comments
AGENCY:
The National Archives and
Records Administration (NARA)
publishes notice of certain Federal
agency requests for records disposition
authority (records schedules). We
publish notice in the Federal Register
and on regulations.gov for records
schedules in which agencies propose to
dispose of records they no longer need
to conduct agency business. We invite
public comments on such records
schedules.
DATES: NARA must receive comments
by December 6, 2019.
ADDRESSES: You may submit comments
by either of the following methods. You
must cite the control number, which
appears on the records schedule in
parentheses after the name of the agency
that submitted the schedule.
SUMMARY:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
56475
• Federal eRulemaking Portal: https://
www.regulations.gov.
• Mail: Records Appraisal and
Agency Assistance (ACR); National
Archives and Records Administration;
8601 Adelphi Road; College Park, MD
20740–6001.
FOR FURTHER INFORMATION CONTACT:
Records Management Operations by
email at request.schedule@nara.gov, by
mail at the address above, or by phone
at 301–837–1799.
SUPPLEMENTARY INFORMATION:
Public Comment Procedures
We are publishing notice of records
schedules in which agencies propose to
dispose of records they no longer need
to conduct agency business. We invite
public comments on these records
schedules, as required by 44 U.S.C.
3303a(a), and list the schedules at the
end of this notice by agency and
subdivision requesting disposition
authority.
In addition, this notice lists the
organizational unit(s) accumulating the
records or states that the schedule has
agency-wide applicability. It also
provides the control number assigned to
each schedule, which you will need if
you submit comments on that schedule.
We have uploaded the records
schedules and accompanying appraisal
memoranda to the regulations.gov
docket for this notice as ‘‘other’’
documents. Each records schedule
contains a full description of the records
at the file unit level as well as their
proposed disposition. The appraisal
memorandum for the schedule includes
information about the records.
We will post comments, including
any personal information and
attachments, to the public docket
unchanged. Because comments are
public, you are responsible for ensuring
that you do not include any confidential
or other information that you or a third
party may not wish to be publicly
posted. If you want to submit a
comment with confidential information
or cannot otherwise use the
regulations.gov portal, you may contact
request.schedule@nara.gov for
instructions on submitting your
comment.
We will consider all comments
submitted by the posted deadline and
consult as needed with the Federal
agency seeking the disposition
authority. After considering comments,
we will post on regulations.gov a
‘‘Consolidated Reply’’ summarizing the
comments, responding to them, and
noting any changes we have made to the
proposed records schedule. We will
then send the schedule for final
E:\FR\FM\22OCN1.SGM
22OCN1
]]>Agencies
[Federal Register Volume 84, Number 204 (Tuesday, October 22, 2019)]
[Notices]
[Pages 56474-56475]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23020]
=======================================================================
-----------------------------------------------------------------------
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
[Notice: (19-070)]
Name of Information Collection: NASA Software Release Request
System
AGENCY: National Aeronautics and Space Administration (NASA).
ACTION: Notice of information collection--new information collection.
-----------------------------------------------------------------------
SUMMARY: The National Aeronautics and Space Administration, as part of
its
[[Page 56475]]
continuing effort to reduce paperwork and respondent burden, invites
the general public and other Federal agencies to take this opportunity
to comment on proposed and/or continuing information collections.
DATES: Comments are due by December 23, 2019.
ADDRESSES: All comments should be addressed to Claire Little, National
Aeronautics and Space Administration, 300 E Street SW, Washington, DC
20546-0001.
FOR FURTHER INFORMATION CONTACT: Requests for additional information or
copies of the information collection instrument(s) and instructions
should be directed to Claire Little, NASA Clearance Officer, NASA
Headquarters, 300 E Street SW, JF0000, Washington, DC 20546 or email
[email protected].
SUPPLEMENTARY INFORMATION:
I. Abstract
NASA Software Release Request System (SRRS) is a workflow tool that
allows Agency Software Release Authorities (SRAs) to easily develop and
route software release documents, such as the Software Release Request
Authorization (SRRA) and Section 508 Compliance Matrix in an automated
fashion. SRAs have the added ability to perform parallel routing,
including the use of time-based email reminders, tracking and reporting
progress on the processing of the software release requests so they can
effectively manage this process at their respective centers. Software
owners/developers can submit the Software Release Requests or view
their submitted Software Release Requests that may need their
attention.
II. Methods of Collection
Web based--only accessible via NASA's internal network (e.g., on
site or remotely via a NASA issued VPN)
III. Data
Title: NASA Software Release Request System.
OMB Number: 2700-xxxx.
Type of review: New Information Collection.
Affected Public: NASA Funded Contractors and Government Employees.
Average Expected Annual Number of Activities: On average 126
software packages are released per year.
Average number of Respondents per Activity: At least one respondent
will complete the form per activity (software release) which will
result in approximately 126 respondents.
Annual Responses: 126.
Frequency of Responses: As needed.
Average minutes per Response: 240 minutes.
Burden Hours: 504.
IV. Request for Comments
Comments are invited on: (1) Whether the proposed collection of
information is necessary for the proper performance of the functions of
NASA, including whether the information collected has practical
utility; (2) the accuracy of NASA's estimate of the burden (including
hours and cost) of the proposed collection of information; (3) ways to
enhance the quality, utility, and clarity of the information to be
collected; and (4) ways to minimize the burden of the collection of
information on respondents, including automated collection techniques
or the use of other forms of information technology.
Comments submitted in response to this notice will be summarized
and included in the request for OMB approval of this information
collection. They will also become a matter of public record.
Cheryl Parker,
Federal Liaison Officer.
[FR Doc. 2019-23020 Filed 10-21-19; 8:45 am]
BILLING CODE 7510-13-P
